$337M | ||
$259M | ||
$79M | ||
$76M | ||
$60M | ||
$57M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Over the last 12 months, insiders at Bluejay Diagnostics, Inc. have bought $0 and sold $0 worth of Bluejay Diagnostics, Inc. stock.
On average, over the past 5 years, insiders at Bluejay Diagnostics, Inc. have bought $61,573 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 500 shares for transaction amount of $1,635 was made by Dey Indranil (President and CEO) on 2023‑12‑13.
2023-12-13 | Dey Indranil | President and CEO | 500 0.044% | $3.27 | $1,635 | -85.64% | ||
2023-12-13 | Dey Svetlana | director | 500 0.0413% | $3.07 | $1,535 | -85.64% | ||
2023-03-28 | Dey Indranil | President and CEO | 2,000 0.0105% | $0.44 | $880 | -49.65% | ||
2023-03-27 | Dey Indranil | President and CEO | 8,000 0.0393% | $0.44 | $3,520 | -53.01% | ||
2023-03-24 | Dey Svetlana | director | 10,000 0.0502% | $0.44 | $4,400 | -51.67% | ||
2022-08-26 | Fisher Kenneth R | Chief Financial Officer | 20,000 0.0992% | $1.03 | $20,600 | -57.23% | ||
2022-04-25 | Fisher Kenneth R | Chief Financial Officer | 20,000 0.0943% | $0.99 | $19,800 | -21.74% | ||
2022-03-17 | Wurth Douglas Clark | 40,000 0.1983% | $1.18 | $47,120 | -24.35% | |||
2022-03-17 | Kinder Gordon Winston | Chief Financial Officer | 2,500 0.0122% | $1.16 | $2,898 | -24.35% | ||
2022-03-17 | Dey Svetlana | 10,000 0.0498% | $1.18 | $11,830 | -24.35% | |||
2022-03-16 | Wurth Douglas Clark | 60,000 0.2823% | $1.09 | $65,400 | -20.91% | |||
2022-03-14 | Kinder Gordon Winston | Chief Financial Officer | 5,000 0.0274% | $1.02 | $5,100 | +1.69% |
Increased Positions | 6 | +33.33% | 2,476 | +12.18% |
Decreased Positions | 9 | -50% | 18,952 | -93.24% |
New Positions | 3 | New | 1,346 | New |
Sold Out Positions | 9 | Sold Out | 18,952 | Sold Out |
Total Postitions | 15 | -16.67% | 3,849 | -81.06% |
Ubs Group Ag | $4.00 | 0.2% | 1,945 | +716 | +58.26% | 2024-12-31 |
Cvi Holdings, Llc | $3.00 | 0.13% | 1,323 | +1,323 | New | 2024-06-30 |
Tower Research Capital Llc (Trc) | $1.00 | 0.06% | 554 | +411 | +287.41% | 2024-12-31 |
Sbi Securities Co., Ltd. | $0 | <0.01% | 20 | +20 | New | 2025-03-31 |
Bank Of America Corp /De/ | $0 | 0% | 4 | +3 | +300% | 2024-12-31 |
Osaic Holdings, Inc. | $0 | 0% | 3 | +3 | New | 2024-12-31 |
Hrt Financial Lp | $0 | 0% | 0 | -793 | Sold Out | 2024-12-31 |
Citadel Advisors Llc | $0 | 0% | 0 | -1,044 | Sold Out | 2024-12-31 |
Anson Funds Management Lp | $0 | 0% | 0 | -6,386 | Sold Out | 2024-12-31 |
Geode Capital Management, Llc | $0 | 0% | 0 | -404 | Sold Out | 2024-12-31 |